Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review.
Cheng-Wei LiuShih-Lung ChengPublished in: Life (Basel, Switzerland) (2022)
This narrative review provides an overview of recent studies on the use of HFNC in patients with COVID-19-related acute hypoxemic respiratory failure. The main topics discussed include the probability of successful use of HFNC in these patients, whether late intubation increases mortality, the availability of convenient and accurate monitoring tools, comparison of HFNC with other types of noninvasive respiratory support, whether HFNC combined with the prone position is more clinically useful, and strategies to further reduce the infection risk associated with HFNC. The implication of this study is to identify some of the limitations and research gaps of the current literature and to give some advice for future research.
Keyphrases
- respiratory failure
- extracorporeal membrane oxygenation
- mechanical ventilation
- end stage renal disease
- ejection fraction
- sars cov
- coronavirus disease
- acute respiratory distress syndrome
- chronic kidney disease
- prognostic factors
- risk factors
- high resolution
- cardiovascular disease
- mass spectrometry
- patient reported outcomes
- respiratory syndrome coronavirus
- hepatitis b virus
- chronic rhinosinusitis
- positive airway pressure